TAUNS Laboratories, Inc.JP:197A
| Jun 30, 2021 | Jun 30, 2022 | Jun 30, 2023 | Jun 30, 2024 |
---|
Cash and deposits | - | 6,347 | 1,244 | 9,425 |
---|
Accounts receivable - trade | - | 942 | 3,051 | 2,707 |
---|
Merchandise and finished goods | - | 1,908 | 1,999 | 2,731 |
---|
Work in process | - | 1,707 | 1,266 | 846 |
---|
Raw materials and supplies | - | 972 | 1,323 | 1,140 |
---|
Other | - | 17 | 15 | 3 |
---|
Income taxes refund receivable | - | - | 344 | 16 |
---|
Current assets | - | 12,036 | 9,457 | 16,916 |
---|
Consumption taxes refund receivable | - | - | 86 | - |
---|
Advance payments to suppliers | - | 83 | 111 | 17 |
---|
Prepaid expenses | - | 58 | 19 | 31 |
---|
Other | - | 17 | 15 | 3 |
---|
Current assets | - | 12,036 | 9,457 | 16,916 |
---|
Construction in progress | - | 218 | 497 | 3,973 |
---|
Buildings | - | 1,004 | 1,028 | 1,100 |
---|
Structures | - | 4 | 8 | 10 |
---|
Property, plant and equipment | - | 3,683 | 4,402 | 7,905 |
---|
Machinery and equipment | - | 1,119 | 1,683 | 1,824 |
---|
Vehicles | - | 83 | 78 | 68 |
---|
Tools, furniture and fixtures | - | 617 | 750 | 837 |
---|
Land | - | 1,735 | 1,735 | 1,735 |
---|
Construction in progress | - | 218 | 497 | 3,973 |
---|
Accumulated depreciation and impairment | - | -1,097 | -1,377 | -1,641 |
---|
Property, plant and equipment | - | 3,683 | 4,402 | 7,905 |
---|
Customer-related intangible assets | - | 3,181 | 2,954 | 2,726 |
---|
Patent right | - | 4 | 3 | 3 |
---|
Technology-related intangible assets | - | 895 | 796 | 696 |
---|
Software | - | 58 | 56 | 44 |
---|
Other | - | - | 101 | 251 |
---|
Customer-related intangible assets | - | 3,181 | 2,954 | 2,726 |
---|
Intangible assets | - | 4,138 | 3,910 | 3,721 |
---|
Technology-related intangible assets | - | 895 | 796 | 696 |
---|
Other | - | - | 101 | 251 |
---|
Intangible assets | - | 4,138 | 3,910 | 3,721 |
---|
Other | - | 72 | 75 | 28 |
---|
Investment securities | - | 181 | 33 | 33 |
---|
Investments and other assets | - | 412 | 563 | 720 |
---|
Shares of subsidiaries and associates | - | 2 | 302 | 452 |
---|
Bonds of subsidiaries and associates | - | 180 | 184 | 187 |
---|
Investments in other securities of subsidiaries and associates | - | 26 | 19 | 14 |
---|
Investments in capital | - | 0 | 0 | 0 |
---|
Distressed receivables | - | 77 | 77 | - |
---|
Long-term prepaid expenses | - | 0 | - | 5 |
---|
Other | - | 72 | 75 | 28 |
---|
Allowance for doubtful accounts | - | -127 | -127 | - |
---|
Investments and other assets | - | 412 | 563 | 720 |
---|
Non-current assets | - | 8,232 | 8,875 | 12,346 |
---|
Assets | - | 20,268 | 18,332 | 29,261 |
---|
Accounts payable - trade | - | 1,391 | 1,143 | 1,483 |
---|
Short-term borrowings | - | 1,200 | 3,500 | 4,500 |
---|
Current portion of long-term borrowings | - | 732 | 732 | 732 |
---|
Accounts payable - facility | - | 166 | 134 | 171 |
---|
Accounts payable - other | - | 357 | 359 | 559 |
---|
Income taxes payable | - | 3,576 | - | 1,706 |
---|
Accounts payable - facility | - | 166 | 134 | 171 |
---|
Provision for bonuses | - | 141 | 109 | 428 |
---|
Accrued expenses | - | 170 | 131 | 166 |
---|
Income taxes payable | - | 3,576 | - | 1,706 |
---|
Current liabilities | - | 8,937 | 6,518 | 10,474 |
---|
Accrued consumption taxes | - | 945 | - | 388 |
---|
Refund liability | - | 26 | 284 | 241 |
---|
Contract liabilities | - | 132 | 20 | 10 |
---|
Deposits received | - | 93 | 78 | 63 |
---|
Provision for bonuses | - | 141 | 109 | 428 |
---|
Provision for bonuses for directors (and other officers) | - | 8 | 28 | 28 |
---|
Current liabilities | - | 8,937 | 6,518 | 10,474 |
---|
Long-term borrowings | - | 2,968 | 2,236 | 4,307 |
---|
Deferred tax liabilities | - | 867 | 922 | 619 |
---|
Provision for retirement benefits | - | 128 | 154 | 182 |
---|
Asset retirement obligations | - | 12 | 12 | 12 |
---|
Non-current liabilities | - | 3,975 | 3,324 | 5,120 |
---|
Liabilities | - | 12,912 | 9,842 | 15,595 |
---|
Share capital | - | 100 | 100 | 200 |
---|
Capital surplus | - | 2,783 | 2,783 | 2,683 |
---|
Legal capital surplus | - | 25 | 25 | 50 |
---|
Other capital surplus | - | 2,758 | 2,758 | 2,633 |
---|
Capital surplus | - | 2,783 | 2,783 | 2,683 |
---|
Retained earnings | - | 4,469 | 5,604 | 10,778 |
---|
Retained earnings brought forward | - | 4,469 | 5,604 | 10,778 |
---|
Retained earnings | - | 4,469 | 5,604 | 10,778 |
---|
Shareholders' equity | - | 7,352 | 8,487 | 13,667 |
---|
Valuation difference on available-for-sale securities | - | -4 | -7 | -8 |
---|
Valuation and translation adjustments | - | -4 | -7 | -8 |
---|
Share acquisition rights | - | 8 | 10 | 8 |
---|
Net assets | 4,679 | 7,356 | 8,490 | 13,667 |
---|
Liabilities and net assets | - | 20,268 | 18,332 | 29,261 |
---|